Omzo vs Sprout Health: Compounded GLP-1 Options Compared
Quick verdict: Omzo emphasizes clinician-guided, personalized compounded semaglutide plans starting at $179 and options for branded prescriptions, while Sprout Health emphasizes fast, low-friction entry with $50 off the first month and a lightning-quick approval process. This comparison focuses on clinician involvement, pricing and promotions, compounded medication status, onboarding speed, and outcome framing for Omzo vs Sprout Health.
Explore Omzo clinician-guided plans
How Omzo and Sprout Health differ in clinician guidance and prescribing
Both providers connect patients to licensed clinicians, but Omzo repeatedly frames its service as clinician-guided plans reviewed by licensed U.S. providers and notes that providers make the final determination as to whether to prescribe any medication. Sprout Health also uses licensed clinicians and requires a clinician to determine medical appropriateness, with an emphasis on fast review and approval. For Omzo, the platform clarifies that clinical services are provided by third party networks of U.S.-licensed clinicians and that the assessment does not create a doctor patient relationship.
Direct comparison
- Omzo: Clinician-guided plans reviewed by licensed U.S. providers; providers determine eligibility and prescriptions.
- Sprout Health: Licensed clinicians review intake with what it calls lightning-quick approval; treatment is available only when a clinician determines it is medically appropriate.
Pricing, promotions, and cost structure
Price presentation differs. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 as part of its offerings. Sprout Health promotes a $50 off first month offer that brings an initial price to $199 with ongoing pricing described as $249/month after the discount period. The Sprout Health captured materials explicitly note the ongoing rate is higher than several competitors.
See Sprout Health first month offer
Compounded medication status and regulatory notes
Both sources refer to compounded medication options. Omzo states its primary program provides access to compounded medications prepared and shipped by a state licensed sterile compounding pharmacy and explicitly notes these compounded drugs are not FDA approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Sprout Health materials also indicate compounded medications, when offered, are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Omzo additionally describes that providers may instead write prescriptions for branded FDA approved medications, but Omzo does not sell or ship branded medications.
Onboarding speed and outcome framing
Sprout Health emphasizes a lightning-quick approval process and frames outcomes around losing 10 to 26 percent of body weight in 12 months, while noting individual results vary and that it does not offer a formal outcome guarantee. Omzo highlights personalized GLP-1 care and includes a patient anecdote about three months of care, but does not supply the same explicit 10 to 26 percent outcome framing in the captured evidence. Neither provider guarantees outcomes and both materials state individual results may vary.
Comparison table: Omzo vs Sprout Health
| Criteria | Omzo | Sprout Health |
|---|---|---|
| Clinician review | Clinician-guided plans reviewed by licensed U.S. providers; providers decide prescriptions | Licensed clinician review with lightning-quick approval; clinician determines medical appropriateness |
| Starting price / promotion | Semaglutide starting at $179; tirzepatide starting at $279 | $50 off first month to $199; ongoing $249/month after discount (captured materials) |
| Compounded meds | Compounded program from state licensed sterile compounding pharmacy; compounded drugs are not FDA approved | Compounded medications when offered are not FDA approved |
| Branded meds | Providers may write prescriptions for branded medications; Omzo does not sell or ship branded products | No branded Ozempic or Wegovy offered in captured materials |
| Onboarding speed | Clinician-guided approach with provider assessment | Lightning-quick approval and fast, low-friction entry |
| Outcome messaging | Patient anecdote after three months; no guarantees | Frames 10 to 26 percent body weight loss over 12 months; no formal outcome guarantee |
Other practical notes from captured evidence
Omzo states it associates with certified U.S. pharmacies and that medication costs are included in fees collected by Omzo. Omzo emphasizes shipping policy and FSA and HSA eligibility language in its short bullets. Sprout Health describes itself as direct-pay with no insurance billing in the captured FAQ and warns that ongoing pricing should be considered for budgeting.
Final thoughts on Omzo vs Sprout Health
Omzo vs Sprout Health boils down to priorities: Omzo centers clinician-guided, personalized plans with compounded and potential branded prescription pathways and lists semaglutide starting at $179. Sprout Health centers speed and a clear first month promotion with $50 off and what it calls lightning-quick approval, with ongoing pricing noted at $249/month in captured materials. Both use licensed clinicians and both note compounded medications are not FDA approved. Compare clinician involvement, starting cost and ongoing pricing, compounded status, and onboarding speed when deciding between them.
Check Sprout Health enrollment and pricing
Choose Omzo if…
You want clinician-guided, personalized GLP-1 plans reviewed by licensed U.S. providers, access to both compounded medications through a state licensed sterile compounding pharmacy, and the option that a provider may write a prescription for branded medications while Omzo does not dispense branded products.
Choose Sprout Health if…
You prioritize a fast, low-friction onboarding experience with lightning-quick approval and a clear introductory promotion of $50 off the first month, keeping in mind the captured materials list ongoing pricing of $249/month after the discount period.